通过改变的糖溶解,PFKP调解乳腺癌转移
Summayya Anwar1, Farhan Haq1, Muhammad Saeed1
1Biosciences, Commission on Science and Technology for Sustainable Development in the South (COMSATS) University Islamabad, Islamabad, PAK.
Cureus
|August 18, 2025
概括
研究人员确定了果酸酶-血小板 (PFKP) 作为乳腺癌转移的关键驱动因素. 向PFKP可能为抗击转移提供新的策略,并改善患者的生存结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 乳腺癌转移对患者的生存和治疗疗效构成重大挑战.
- 迫切需要新的治疗目标,以有效管理转移性乳腺癌.
- 基因分析的进步凸显了识别新转移驱动因素的必要性.
研究的目的:
- 为了确定驱动乳腺癌转移的新型分子标.
- 阐明这些目标促进转移的潜在机制.
- 评估已识别的标作为乳腺癌转移的预后标记物的潜力.
主要方法:
- 使用基因表达综合 (GEO) 数据集进行差异基因表达分析.
- 在外部数据集中验证基因表达变化.
- 定量实时聚合酶连锁反应 (qRT-PCR) 用于PFKP和Ki67表达分析.
- 生存分析和接收器运行特征 (ROC) 曲线分析.
主要成果:
- 在转移性乳腺瘤中确定了34个差异表达的基因;PFKP被显著上调.
- PFKP表达与与糖溶解相关的基因,缺氧和血管生成途径相关.
- 在患者样本中证实了PFKP上调,并与Ki67表达相关.
- 高的PFKP表达作为转移的预测标记,并与患者的生存率低下有关.
结论:
- 通过低氧诱导的糖解变化,PFKP促进乳腺癌转移.
- PFKP是识别乳腺癌转移的潜在预后标志物.
- 向PFKP可能代表了一种针对乳腺癌转移的新疗法策略.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K


